Physician profile
Eric Thomas
NPI 1447741178
$13,264.80
in general payments reported to CMS, 2019-2025
39 companies · $2,197 in 2025
The $2,197 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,684 · 2020: $744 · 2021: $707 · 2022: $2,263 · 2023: $2,997 · 2024: $2,672 · 2025: $2,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,171 · Travel and Lodging: $1,685 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,171.09 |
| Travel and Lodging | $1,685.01 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,037.00 | 2019-2025 | Altis, Titan, Isiris Astent Removal Device |
| Boston Scientific Corporation | $2,004.56 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Gateway Advantage |
| Olympus Corporation of The Americas | $1,148.35 | 2019-2020 | |
| Axonics, INC. | $1,102.11 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $951.49 | 2021-2025 | Interstim, Ligasure |
| Teleflex LLC | $627.91 | 2023-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $599.96 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Urogen Pharma, INC. | $473.70 | 2022-2025 | Jelmyto |
| Palette Life Sciences, INC. | $328.75 | 2020-2023 | |
| Cook Medical LLC | $309.34 | 2020-2023 | Fiber Dust |
| Ferring Pharmaceuticals INC. | $305.81 | 2024-2025 | Adstiladrin |
| Olympus America INC. | $304.73 | 2019-2025 | Itind System, Olympus, Soltive |
| Endo Pharmaceuticals INC. | $270.59 | 2019-2023 | Xiaflex |
| Aroa Biosurgery Incorporated | $221.31 | 2023 | |
| Janssen Biotech, INC. | $205.64 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $188.96 | 2023-2025 | Gemtesa, Orgovyx |
| Richard Wolf Medical Instruments Corp. | $124.96 | 2019 | |
| Progenics Pharmaceuticals, INC. | $100.00 | 2023 | Pylarify |
| Myovant Sciences INC. | $93.85 | 2022 | |
| Astellas Pharma US INC | $80.14 | 2023-2024 | Myrbetriq, Veozah |
| Merck Sharp & Dohme LLC | $75.54 | 2022-2025 | Keytruda |
| Endo USA, INC. | $71.83 | 2024-2025 | Xiaflex, Aveed |
| Tolmar, INC. | $70.91 | 2024-2025 | Eligard, Jatenzo |
| Profound Medical Corp. | $70.69 | 2025 | Tulsa-Pro |
| Novartis Pharmaceuticals Corporation | $67.75 | 2019-2020 | |
| Dentsply Ih INC. | $62.11 | 2021 | |
| Laborie Medical Technologies Corp. | $51.31 | 2025 | |
| Bioprotect Medical, INC. | $47.69 | 2025 | Bioprotect Balloon Implant System |
| Medtronic USA, INC. | $41.61 | 2020 | |
| Myriad Genetic Laboratories, INC. | $39.33 | 2023 | Prolaris |
| Neotract INC. | $34.98 | 2020 | |
| Abbvie INC. | $25.91 | 2022 | |
| Dendreon Pharmaceuticals LLC | $21.10 | 2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $21.06 | 2019 | |
| Celgene Corporation | $20.99 | 2023 | |
| Baxter Healthcare | $18.64 | 2019 | |
| Angiodynamics, INC. | $15.60 | 2025 | Nanoknife |
| Conmed Corporation | $15.29 | 2025 | Airseal |
| Photocure INC | $13.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.